Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Drug relieves chronic pain without the addiction risk (News)

Submitted by baileylynn_100964 on Thu, 12/30/2021 - 20:16

Drug relieves chronic pain without the addiction risk

Futurity
17 February 2021
https://www.futurity.org/naltrexone-chronic-pain-addiction-opioids-2519…

A low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, researchers report.

 

Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"

Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NA%3D%3D

In Response Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"

Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NQ%3D%3D

 

Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Pain Presentation

 

Darin Ingels, ND - LDN and Children (2017 Conference) (LDN, low dose naltrexone)

Research on LDN in children shows it is safe with low side effects. Studies where LDN was used successfully in children: 2 with Crohn’s, 2 with autism, 1 with CRPS. His cases: autism; Hashimoto’s; IBS.

 

Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

 

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

 

Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)